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Background: Myofibroblasts (MF) and angiogenesis are important factors in the development and expansion of 
cystic lesions, where these cells secrete growth factors and proteases, stimulating angiogenesis, matrix deposition 
and cell migration, affecting the growth of these periapicopathies. The present study aimed to evaluate the immu-
nohistochemical expression of CD34 and α-SMA in radicular cysts (RC) and residual radicular cysts (RRC), with 
the purpose of contributing to a better understanding of the expansion and progression of these periapical lesions.
Material and Methods: The present study os a descriptive, quantitative and comparative analysis of positive CD34 
and α-SMA immunohistochemical expressions in 30 RC and 30 RRC specimens. α-SMA expression was evaluated 
in the fibrous capsule of the lesions, at 100x magnification below the epithelial lining. A total of 10 higher immunos-
taining fields were selected and subsequently, positive cells were quantified at 400x magnification, averaged per field. 
Regarding the angiogenic index, immuno-labeled microvessel counts for the anti-CD34 antibody were performed in 
10 fields at 200x magnification.
Results: Statistically significant differences regarding α-SMA immunostaining were observed (p = 0.035), as well 
as a correlation between α-SMA versus CD34 (p = 0.004) in RRC. However, the angiogenic index obtained by im-
munostaining for CD34 indicated no statistical difference between lesions. Intense inflammatory infiltrates were 
predominant in RC, while mild and moderate degrees were more commonly observed in RRC (p <0.001). Intense 
inflammatory infiltrates were also more often noted in larger RRC (p = 0.041). Inflammatory infiltrates showed no 
significant correlation with α-SMA and CD34 immunostaining.
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sity, in Brazil between years range from January 2008 
to January 2019. Only specimens presenting sufficient 
biological quality and quantity were selected for the 
study. For both cases (RC and RRC), only fragments ex-
hibiting pathological cavity coated entirely or partially 
by epithelium and a sufficient amount of fibrous capsule 
to perform immunohistochemical evaluations were se-
lected. Information regarding gender, age, anatomical 
location, symptomatology and lesion size were collect-
ed. Clinical records with insufficient information con-
cerning these variables were excluded from the study.
- Morphological analysis
The selected cases RC and RRC cases were cut into 5 
µm-thick samples, stained by Hematoxylin/Eosin (HE) 
technique and analyzed under light microscopy (Olym-
pus BX41, Olympus Japan Co., Tokyo, Japan) at 40x, 
100x, and 400x magnifications. Inflammatory infil-
trate intensities were analyzed at 400x magnification 
according to an adaptation of the França et al. criteria 
(8). Nine microscopic fields were selected, divided into 
sets of three consecutive fields starting the epithelium 
analysis and extending deep into the capsule. Speci-
mens whose inflammatory infiltrate was restricted to 
1/3 of the microscopic field were considered as Grade 
I (mild infiltrate); lesions with inflammatory cells pres-
ent in up to 2/3 of the microscopic field were defined as 
Grade II (moderate infiltrate); and lesions that exhibited 
inflammatory infiltrate in over 2/3 of the microscopic 
field were categorized as Grade III (intense infiltrate). 
At the end, the average of each set of three fields was 
calculated and the intensity of the inflammatory infil-
trate of the case was established. The thickness of the 
epithelial lining of the cysts was analyzed according to 
the methodology proposed by França et al. (8). Under 
this perspective, cystic epithelia presenting from 2 to 10 
layers in their greatest extent and hyperplastic above 10 
layers were considered atrophic.
Data related to the size of cystic lesions were obtained 
by macroscopic measurement and were categorized 
into three groups according to their largest dimension 
in centimeters (cm): group 1 (≤ 2 cm); group 2 (> 2 to 4 
cm) and group 3 (> 4 cm) (9).
- Immunohistochemical analysis
The α-SMA immunostaining (DAKO, Carpinteria, CA, 
USA), clone (1A4), specification (Monoclonal), dilu-
tion (1:500), antigen retrieval (Trilogy), incubation (60’) 
was performed to identify myofibroblasts. The CD34 
antibody (CELL MARQUE, MilliporeSigma, USA), 
Introduction
Periapical lesions are inflammatory conditions of the 
periradicular tissues resulting from direct sequelae of 
pulp necrosis infections and consequent progression 
to the apical region (1), linked to the fragility of host 
defense mechanisms in removing contamination by 
persistence of antigenic agents (2). Inflammation of the 
necrotic tooth pulp results in proliferation of Malassez 
epithelial remains, which are Hertwig’s root epithelial 
sheath remnants that become stimulated to proliferate, 
giving rise to radicular cysts (RC) (3).
Myofibroblasts (MF) are connective tissue cells that 
exhibit a hybrid phenotype, morphologically presenting 
as large and spindle-shaped cells, exhibiting character-
istics between those of fibroblasts and smooth muscle 
cells (4). The presentation of such a phenotype is due 
to a transdifferentiation process, characterized by the 
expression of smooth muscle α-actin (α-SMA), a protein 
essential for MF identification, which are recognized in 
cystic and tumoral lesions, controlling phenomena such 
as tissue reorganization capacity (4) and angiogenesis 
through the secretion of inflammatory mediators, che-
mokines and platelet-derived growth factor (PDGF) (5).
Regarding inflammatory odontogenic lesions, scarce 
research analyzing the expression of α-SMA and CD34 
in periapical lesions is available. In this context, this 
study aims to evaluate the pathogenesis and growth of 
periapical cystic lesions assessed through immunohis-
tochemical expression analyses.
Material and Methods
- Study design and tissue samples
The research is a cross-sectional and retrospective study. 
The sample was selected non-probabilistically and for 
convenience based on consecutive cases and specimens 
derived from total surgical removal. The calculation for 
the sample size was determined by the prevalence of the 
lesions. The prevalence of RCs was 29.2% obtained by 
Becconsall-Ryan et al. (6). For RRCs, the prevalence of 
4.9% was obtained by Souza et al. (7), adopting 5% al-
pha error, 80% test power and 20% beta error, 3% con-
fidence interval amplitude, resulted in a minimum size 
of 28 cases for RCs and 6 cases for RRCs, according to 
the formula: n= (z2 pq)/(FE2).
Thirty radicular cyst (RC) and thirty residual radicular 
cysts (RRC) cases were obtained from the pathology re-
cords of the Postgraduate Program in Oral Pathology 
belonging to the Rio Grande do Norte Federal Univer-
Conclusions: The results indicate that the significant correlation found between the presence of MF and the angiogenic 
index are related to the repair process in RRC.
Key words: Myofibroblasts, angiogenesis, inflammatory odontogenic cysts.
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clone (QBEnd/10), specification (Monoclonal), dilution 
(1:200), antigen retrieval (Trilogy), incubation (60’) was 
used to determine the angiogenic index.
Histological 3 µm thick sections were obtained and spread 
on previously cleaned glass slides prepared with 3-ami-
nopropyltriethoxy silane adhesive (Sigma Chemical 
CO, St Louis, MO, USA). The material was subsequent-
ly subjected to the antibodies through the immunohis-
tochemistry technique applying the streptoavidin-bi-
otin method (LSAB-estroptoavidin biotin complex).
Positive controls for the α-SMA and CD34 antibodies 
were performed with histological capillary hemangio-
ma sections. The negative control consisted of replacing 
the primary antibody with 1% bovine serum albumin 
(BSA) in a buffer solution, followed by all subsequent 
steps of the protocol described as follows: 1) All sam-
ples were immersed in a prepared solution containing 
Trilogy® in one contained, followed by tissue sample 
immersion in a paschal pot for deparaffinization, re-
hydration and antigenic site recovery; 2) The material 
was then washed under running water for 3 minutes 
with two distilled water washed for 1 minute each; 3) 
The samples were then incubated for 15-minutes in a 
10-volume hydrogen peroxide solution (3%) to block tis-
sue endogenous peroxidase; 4) All samples were then 
washed with distilled water; 5) Samples were then im-
mersed in a 1% Tween20 solution in TRIS-HCl pH 7.4 
for 5 minutes each; 6) Samples were then incubated 
with Background Block protein (Cell Marque, Rocklin, 
California, USA) for 10 minutes; 7) Samples were in-
cubated with diluted primary antibodies (Envision Flex 
Antibody Diluent - DM830), for 60 minutes; 8) Second-
ary antibody incubation was then carried out using the 
Hi Def Detection System (Cell Marque; Rocklin, Cali-
fornia, USA) applying the amplification solution for 20 
minutes; 9) The HiP System HRP polymer was then ap-
plied for 20 minutes; 10) Application of the DAB chro-
mogen agent (diaminobenzidine; Scytek Laboratories; 
Logan, Utah, USA) was then performed for 5 minutes 
at room temperature; 11) Samples were then counter-
stained with Mayer’s hematoxylin at room temperature 
for 5 minutes; 12) quick washes in distilled water (three 
changes) were then performed; 13) Ethanol upstream 
dehydration was performed, as follows: Ethyl alcohol 
80° GL (3 minutes), Ethyl alcohol 95° GL (3 minutes), 
Absolute Ethyl Alcohol I (5 minutes), Absolute Ethyl 
Alcohol II (5 minutes), Absolute Ethyl Alcohol III (5 
minutes), Xylol I immersion (5 minutes) and, finally, 
Xylol II immersion (5 minutes).
- Immunohistochemical profile analysis
Each case was analyzed by 2 pre-calibrated examiners 
under light microscopy (Olympus BX41, Olympus Ja-
pan Co., Tokyo, Japan). The slides were then scanned 
(Panoramic MIDI, 1.15 SPI, 3D HISTECH, Budapest, 
Hungary) and imaged using the Panoramic Viewer 
1.15.2 software (3D HISTECH, Budapest, Hungary).
MF identification was performed by α-SMA immunos-
taining based on the methodology proposed by Vered et 
al. (10). A total of 10 subepithelial fields with higher im-
munoreactivity were selected using a 100x magnifica-
tion. Positive cells were quantified in each of these fields 
at 400x magnification, eliminating those in the periph-
ery of blood vessels. The obtained values were summed 
and subsequently the positive cells were averaged per 
field and for each case, individually. The examiners 
analyzed the lesions separately and any disagreements 
were reassessed until a consensus was reached.
The angiogenic index was obtained through microvas-
cular counting (MVC), using an adaptation of the Mae-
da et al. method (11). Thus, 10 fields located below the 
epithelial component with the highest immunostaining 
for the CD34 antibody were selected at a 100x magni-
fication. Subsequently, microvessels were quantified in 
each of these fields at 200x magnification. The obtained 
values were then summed, establishing the total num-
ber of microvessels. Finally, the average number of mi-
crovessels per field was calculated in each case.
- Statistical analyses
The immunohistochemical analysis results were entered 
into an Excel spreadsheet (Microsoft Office 2016®) and 
later exported to the Statistical Package for the Social 
Sciences program (version 24.0; SPSS Inc., Chicago, 
IL, USA), via the freeware version, where the statistical 
analyses were performed.
After applying the Shapiro-Wilk test to determine data 
normality, the statistical analyses were performed using 
the nonparametric Mann-Whitney test to verify statistical 
differences between lesion inflammatory infiltrate degree 
and α-SMA and CD34 immunostaining between lesions.
Spearman’s correlation test was used to cross quanti-
tative variables, such as α-SMA immunoexpression, 
CD34 and lesion size in cm, in addition to the ordinal 
grading of the inflammatory infiltrate. Finally, Pear-
son’s chi-square association test was used to analyze 
the association between epithelial thickness between 
RC and RRC. The confidence interval for all analyses 
was set at 95% and p <0.05.
Results
- Epidemiological and Clinical Results
The sample of the present study was intentional and 
consisted of 60 cases, 30 RC and 30 RRC. Regarding 
gender, female samples were predominantly in RC (4:1 
F:M; n=24; 80.0%) while male samples were predomi-
nantly in RRC (2:1 F:M n=20; 66.7%). Regarding ana-
tomical location, the anterior region of the maxilla was 
the most affected site for both lesions (n=16; 53.3%), 
followed by posterior region of mandible (n=6 in RCs; 
n=6 in RRCs), posterior region of maxilla (n=6 in RCs; 
n=5 in RRCs) and anterior region of mandible (n=2 in 
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RCs; n=3 in RRCs). The mean age for RC cases was 
34.1 ± 13.21, while the mean age for RRC cases was 
52.8 ± 13.34 years. Regarding symptoms, asymptomatic 
cases were predominant for both RCs (n=22; 73.3%) and 
RRCs (n=21; 70.0%).
- Morphological Results
Regarding epithelial thickness, a significant association 
was observed between the epithelial lining and type of 
lesion (Table 1). RC displayed a higher frequency of hy-
perplastic epithelium compared to RRC exhibiting an 
atrophic epithelium (p = 0.037).
The analysis concerning inflammatory infiltrate inten-
sity revealed the predominance of an intense inflam-
matory infiltrate degree in RC, while higher mild and 
moderate degree frequencies were observed for RRC 
(Table 1).
Regarding lesion size, RRC were larger compared to 
RC, presenting an average size of 2.21 ± 0.92 cm in di-
ameter compared to 1.90 ± 1.63 cm in diameter, respec-
tively, considering macroscopic measurements. The RC 
median was of 1.4 (0.5-2.2), while the RRC median was 
of 2.0 (1.4-3.0).
RC did not present significant correlations between size 
and inflammatory infiltrate, while a significant posi-
tive moderate correlation was found for RRC cases (p 




































n Median (Q25-Q75) Median (Q25-Q75)




RRCs 30 31.8 (3.7-77.6)
58.1 
(41.8-75.1)
a* Significant association for the Pearson’s Chi-square test. b* Statistically significant difference for the Mann-Whitney test. P.R (95% CI): 
Prevalence ratio for the 95% confidence interval.
Table 1: Morphological and immunohistochemical characteristics of periapical lesions.
Periapical lesions rs p
Radicular Cyst
Size in cm versus inflammatory infiltrate -0.318 0.087
α-SMA versus inflammatory infiltrate 0.019 0.923
CD34 versus inflammatory infiltrate -0.012 0.949
α-SMA versus size in cm -0.003 0.987
CD34 versus size in cm 0.106 0.579
α-SMA versus CD34 0.226 0.231
Residual Radicular Cyst
Size in cm versus inflammatory infiltrate 0.375 0.041*
α-SMA versus inflammatory infiltrate 0.231 0.219
CD34 versus inflammatory infiltrate -0.148 0.436
α-SMA versus size in cm 0.510 0.004*
CD34 versus size in cm 0.148 0.437
α-SMA versus CD34 0.509 0.004*
*Significant for Spearman’s correlation test. rs: Correlation coefficient.
Table 2: Correlation between α-SMA and CD34 immunoexpression in inflammatory infiltrate 
and size of cystic lesions.
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- Immunohistochemical Results
α-SMA immunoexpression
MF were identified by immunostaining for α-SMA anti-
body in most analyzed cases. The average for RC cases 
was of 23 MF per field and a median of 10.0 (0.0-40.0). 
For RRC, average MF consisted in 42 cells per field and 
a median of 31.8 (3.7-77.6) (Table 1). A statistically sig-
nificant difference between lesions (p = 0.035) regarding 
α-SMA immunoreactivity was observed (Fig. 1).
Fig. 1: α-SMA immunostaining box-Plot in RC and RRC.
Fig. 2: α-SMA immunostaining pattern. A) MF located deep in the connective tissue capsule in RC (Scale Bar: 1000 
μm). B) MF arranged in bundles with the predominantly fusiform form, as well as, strong but focal α-SMA immunos-
taining in the connective tissue capsule containing intense inflammatory infiltrates in RC (Scale Bar: 50 μm). C) MF 
distributed diffusely and almost to the full extent of the connective tissue capsule in RRC (Scale Bar: 100 μm). D) MFs 
are predominantly ovoid and stellate in shape interspersed in the scarce inflammatory infiltrate in RRC (Scale Bar: 50 
μm). E) Strong α-SMA immunostaining adjacent to the hyperplastic epithelium of RRC giving contractile force (Scale 
Bar: 100 μm). F) MFs are predominantly ovoid and fusiform in shape interspersed in the moderate inflammatory infil-
trate in RRC (Scale Bar: 50 μm).
CD34 immunoexpression
Evaluation of immunoblotted lesions by the anti-CD34 
antibody revealed immunoreactivity in endothelial 
cells. The angiogenic index obtained by MVC revealed a 
median of 60.1 (45.8-68.5) for RC and of 58.1 (41.8-75.1) 
for RRC. No statistically significant difference between 
lesions was observed (p = 0.988) (Table 1). A significant 
positive and moderate correlation (p=0.004) was found 
only between α-SMA and CD34 in RRC (Table 2).
The highest concentration of CD34-immunstained ves-
sels was located near the cystic epithelium and was not 
statistically significant related to inflammatory infiltrate 
intensity of epithelial thickness. Larger vessels were 
found in the subepithelial RCs and RRCs region (Fig. 3).
Fig. 3: CD34 immunostaining pattern. A) Photomicrograph indi-
cating large amounts of vessels immunostained with anti-CD34 
antibody in hyperplastic epithelium of RC (Scale Bar: 100 μm). B) 
Numerous and larger caliber vessels immunostained strong for anti-
CD34 antibody near the atrophic epithelial layer in RC with intense 
inflammatory infiltrates (Scale bar: 100 μm). C) Large vessels un-
derlying the hiperplastic epithelium in RRC with intense inflamma-
tory infiltrates (Scale bar: 100 μm). D) Small vessels underlying the 
atrophic epithelium in the scarce inflammatory infiltrates of RRC 
(Scale bar: 50 μm).
α-SMA expression was higher in larger RRC, with a sig-
nificant positive and moderate correlation (p = 0.004). 
No statistical significance was observed for RC (Table 2).
Regarding immunostaining intensity, RC showed strong 
focal α-SMA immunoexpression, located mainly in the 
deep portion of the fibrous connective tissue capsule, 
while RRC showed strong α-SMA immunoexpression 
but diffusely distributed throughout the fibrous connec-
tive tissue capsule (Fig. 2).
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Discussion
Periapical lesions represent a dynamic inflammatory 
reaction. The RRC originate from RC, which remained 
in the bone after inadequate or incomplete surgical pro-
cedures and continue their development (12). It is note-
worthy that the growth and expansion mechanisms of 
these cysts are not completely understood.
RC and RRC present very similar histopathological 
characteristics although, the determining stimulus is 
present in RC and absent in RRC (12). Because these le-
sions are inflammatory in nature, all cases were classi-
fied according to inflammatory infiltrate intensity. The 
examined RC presented intense inflammatory infiltrates 
(70%), corroborating the studies carried out by Andrade 
et al. (13). In turn, most RRC presented mild (36.7%), 
moderate (36.7%) and intense (26.7%) inflammatory in-
filtrates, in line with the aforementioned studies (13). 
Thus, the fact that inflammatory infiltrate intensity was 
higher in RC is related to the intense metabolic activity 
observed in these lesions when compared to RRC, since 
the main antigenic stimuli are no longer present in the 
latter (13).
It is assumed that the hyperplastic epithelial lining is 
characteristic of active lesions. Thus, lesions exhibiting 
atrophic epithelia demonstrate a quiescence status (14). 
The present study revealed a higher frequency of lesions 
presenting hyperplastic epithelium (56.7%) compared 
to atrophic epithelium (43.3%) in RC, in accordance 
to previous studies (14). On the other hand, a higher 
number of lesions presenting atrophic epithelium (70%) 
when compared to hyperplastic epithelium (30%) was 
noted in RRC, similar to the aforementioned study (14).
MFs are characterized by actin microfilament bundles 
(stress fibers) containing smooth muscle α-actin, thus 
presenting high contractile capacity (15). MFs are trans-
differentiated fibroblasts and the beta growth transform-
ing factor (TGF-β) cytokine plays an important role 
in directly promoting their development by inducing 
α-SMA expression (10,16-17). This actin isoform pre-
dominates in vascular smooth muscle cells and its acti-
vation plays an important role in fibrotic response (18).
In this perspective, studies involving inflammatory 
odontogenic lesions reveal that MFs are related to cyst 
growth and expansion, modulating collagen deposi-
tion and angiogenesis mechanisms, as these cells are 
responsible for the synthesis of enzymes capable of de-
grading the extracellular matrix. Thereby controlling 
lesion growth and vascular support through angiogen-
esis (10,16). Unfortunately, few studies on the presence 
of MF in odontogenic cysts are available (2,5,10,18-23) 
and only four address inflammatory odontogenic le-
sions (16-17,24-25).
MF play an important role in inflammatory responses, 
as they secrete inflammatory mediators, growth factors, 
interstitial matrix molecules, chemokines and cytokines 
(5). Thus, the secretion of some factors such as TGF-ß1, 
monocyte chemotactic protein (MCP1) and platelet-de-
rived growth factor (PDGF) have been implicated in the 
appearance of MF and, consequently in the growth of 
several cystic lesions (5,10).
In the present study, MF were present in almost all as-
sessed lesions, with immunoreactivity confined to the 
cytoplasm and/or cell nucleus. A statistically signifi-
cant difference between the presence of MF in the RCs 
and RRCs was observed, with higher concentrations in 
RRC. It is believed that the presence of MFs is essential 
in the physiological construction of scar processes, due 
to their ability to produce collagen, which may be as-
sociated to lesion growth and progression (18).
Growth factors produced by MF, including TGF-ß1 and 
tumor necrosis factor alpha (TNF-α), induce MMP se-
cretion by these cellular elements, playing a role in ex-
tracellular matrix (ECM) remodeling, secreting metal-
loproteinase-2, 13 (MMPs-2, 13), plasminogen activator 
urokinase (uPA), as well as interacting with epithelial 
cells and connective tissue cells, and the activation of 
these enzymes can lead to the release and activation of 
sequestered cytokines and growth factors, which may 
favor angiogenesis and RC and RRC expansion (19). 
Additionally, MF contribute to bone resorption, par-
ticularly in RC (16). MF were present in significantly 
higher amounts in RRC, regardless of size. Larger RRC 
contained intense inflammatory infiltrates, thus justify-
ing the role of inflammation in MMP production by MF 
and RRC expansion.
MFs were detected in almost all analyzed lesions in 
areas below the cystic epithelium and in the capsule 
depth, corroborating the assessment carried out by Sou-
sa-Neto et al. (17), which detected MF in 100% of RC at 
an average of 4.66 cells per field, albeit at slightly lower 
amounts compared to the present study.
MF amounts were higher in RRC when compared to 
RC in the present study. MF are known to play a role 
in repair by promoting tissue remodeling through type 
I, III, IV, VIII collagen secretion, as well as glycopro-
teins such as fibronectin, tenascin, laminin, chondroitin 
sulfate, and matrix metalloproteinases MMP1, MMP2, 
and MMP3 (26). Understanding that repair represents 
one of the late-stage stages of inflammation, MF are 
believed to be higher in RRC because they are more 
chronic lesions than RC (4). Thus, inflammatory cells 
present in RRC are replaced in time by collagen, which 
would explain the higher amounts of MF detected in 
this type of lesion.
According to the results obtained herein, MF seem to 
play a double role in RRC, acting in the repair and con-
tainment of these lesions in cases of mild inflammatory 
infiltrate degrees, as well as in the growth of these peri-
apicopathies in cases of intense inflammatory infiltrate 
degrees. Cystic growth containment is justified by MF 
e590
Myofibroblasts in cystic periapical lesionsMed Oral Patol Oral Cir Bucal. 2020 Sep 1;25 (5):e584-91.
location on RC peripheries and the greater dispersion 
of these cells by the connective tissue capsule of RRC. 
Consequently, as MF are more distributed in the RRC 
capsule, they will become closer to vessels and obtain 
access to more nutrients, allowing for collagen fiber 
deposition and RRC repair. It is noteworthy that cyst 
containment occurs during the quiescence phases and is 
more extensive in RRC. However, during cystic expan-
sion phases, MF act on conjunctive remodeling through 
MMP released by MF, contributing to cystic expansion.
No statistically significant differences were observed 
concerning the interaction between inflammation and 
α-SMA, corroborating the study carried out by Sousa-
Neto et al. (17) who indicated no or infrequent MF in 
inflammation areas, while reporting a greater amount 
of these cells in granulation tissue areas.
The expression of vascular markers may be associated 
with the inflammatory pattern and its progression (10). 
Vascular neoformation supports the inflammatory pro-
cess, as new vessels transport oxygen and nutrients nec-
essary for cellular demands to the inflammation site (3).
Few studies are available concerning the real role of 
vascularization in the development of periapicopathies. 
Connective tissue rich in newly formed blood vessels is 
essential for epithelial tissue maintenance, as it forms 
an ecosystem in which continuous communication oc-
curs between participating cells. Capsule changes in 
these cystic lesions are dependent on MF, TGF-ß1 and 
PDGF released by epithelial cells, which are responsible 
for MF appearance, while low TGF-ß1 concentrations 
are strongly chemotactic for fibroblasts (10).
Based on this assumption, CD34 capsule expressions 
were analyzed. Angiogenesis measurements were per-
formed through microvascular counting, as this is a 
simple, easy and effective method, according to Freitas 
et al. (27). According to Jordan et al. (28), poor endo-
thelial cell immunostaining has been observed in some 
cases,  as delayed fixation (more than 48 hours), inad-
equate dehydration, and excessive paraffin temperature 
(over 54 degrees) may impair the immunohistochemical 
technique and lead to immunostaining changes.
The CD34 marker analysis in RC and RRC indicated 
similar amounts of blood vessels in both lesions. No 
statistically significant differences were observed be-
tween CD34 and inflammatory infiltrates, corroborat-
ing the findings reported by Berar et al. (29). Disagree-
ing with from our results, which revealed a significant 
difference, this difference is probably due to the applied 
methodology (semi-quantitative) (30) and the different 
immunohistochemical marker applied (VEGF) (3).
A higher number of cells in CD34 immunopositive cap-
sules was observed in RC, indicating this lesion pres-
ents higher metabolic and proliferative activity, there-
fore requiring a higher supply of oxygen and nutrients 
when compared to RRC (29). However, no significant 
difference was observed between CD34 expression 
and inflammatory infiltrate intensities in cystic lesions, 
although these immunostained cells are close to the 
inflammatory infiltrate, in agreement with other as-
sessments (30), where authors indicate that some yet un-
known factor may stimulate endothelial cell CD34 ex-
pression, regardless of inflammatory infiltrate intensity.
Potential correlations between the angiogenic index and 
the presence of MF in RC and RRC were also evaluat-
ed, only detected in RRC, corroborating another study 
(17), which found a positive and moderate correlation 
between these indices in RRC. In the case of odonto-
genic lesions, the presence of MF constitutes a source 
of angiogenic proteins, as well as extracellular matrix 
degradation proteinases, which together favor lesion 
growth (10,15).
It is also important to note that angiogenesis also assists 
cyst progression by stimulating the formation of new 
blood vessels, which increase oxygenation, allowing for 
the deposition of the fibrin-rich matrix essential for cell 
migration, greater accumulation of inflammatory cells 
and, consequently, the accumulation of more fluid in the 
cystic cavity (10). Based on this assumption, angiogen-
esis may act contributing to the growth and expansion 
of periapicopathies.
Based on the findings of the present study, this study 
concludes that immunohistochemical expression of 
α-SMA revealed greater immunostaining in RRC com-
pared to RC. Considering inflammatory action, MF act 
favoring cystic expansion, while in the quiescence pe-
riod of the lesion these cellular components act in tissue 
repair, as well as, α-SMA and CD34 immunoexpres-
sion indicate a moderate positive correlation between 
MF and the angiogenic index in RRC, allowing for the 
inference that these proteins may contribute to cystic 
growth containment.
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